Skip to content

Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia

Describe Relationship Between qCON and qNOX of the CONOX Monitor During General Anesthesia Perfromed With Propofol and Remifentanil Target Controlled Infusion (TCI)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06349681
Enrollment
14
Registered
2024-04-05
Start date
2024-04-01
Completion date
2024-10-01
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia Brain Monitoring

Keywords

Anesthesia brain Monitoring, TIVA-TCI, CONOX

Brief summary

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.

Detailed description

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bwtween the 2 indicies, as well as with EMG, Concentration of Propofol (CeP) and Remifentanil (CeR) during Total Intravenous Anesthesia with Target Controlled Infusion (TIVA-TCI).

Interventions

None listed

Sponsors

University of Padova
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld or Schnider model) and Remifentanil (Minto model) and CONOX monitoring

Exclusion criteria

* Neurological disease * Psychiatric disease * Obesity * Locoregional anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Correlation between qCON and qNOXCONOX values will be recorded from start of anesthesia to the return of responsiveness at the end of surgeryqCON and qNOX values from CONOX monitor will be compared

Secondary

MeasureTime frameDescription
Correlation between qCON and concentrations of Propofol(CeP)CONOX and TCI values will be recorded from start of anesthesia to the return of responsiveness at the end of surgeryqCON and CeP values from CONOX monitor and infusion pump will be compared
Correlation between qNOX and concentrations of Remifentanil (CeR)CONOX and TCI values will be recorded from start of anesthesia to the return of responsiveness at the end of surgeryqNOX and CeR values from CONOX monitor and infusion pump will be compared

Countries

Italy

Contacts

Primary ContactFederico Linassi, MD
federico.linassi@gmail.com0422322440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026